Scientists all over the world are racing to find treatments for COVID-19, the disease caused by the novel coronavirus. So far, there are only a few treatments that have been approved for use.
One of these is a class of drugs known as antivirals. Antiviral drugs are a mainstay of treatment for many other viruses, such as HIV, hepatitis C, and influenza.
But there are still many questions about how well they work against COVID-19 and what the best ways to take them are. In this blog post,
So long as life remains, there is always hope… and so long as there is hope, there can be victory!
DIANA PRINCE
we will explore what scientists still want to know about using antiviral drugs to treat COVID-19.
What are COVID antiviral pills?
The new coronavirus, SARS-CoV-2, has scientists scrambling to understand its every nuance. That includes determining which drugs might work against it—and antiviral pills are one potential treatment being studied.
Currently, there are no approved COVID antiviral pills. However, researchers are evaluating a number of existing drugs that have shown promise in preliminary studies. These include:
Remdesivir: This drug was originally developed to treat Ebola and has shown some efficacy against SARS-CoV-2 in animal studies. A small clinical trial suggested it might help hospitalized patients with COVID-19 recover more quickly, although larger trials are needed to confirm these findings.
Favipiravir: This drug is typically used to treat influenza and has shown activity against other RNA viruses, such as dengue fever and West Nile virus. Early data from a clinical trial in China suggested that favipiravir might be effective against COVID-19, but larger studies are needed to confirm these results.
So far, the most promising data for an antiviral pill against COVID-19 comes from a combination of lopinavir and ritonavir (brand name Kaletra), which is typically used to treat HIV. A small study suggested this combo might help patients with milder forms of COVID-19 recover more quickly, but again, larger trials are needed before any firm conclusions can be drawn.
Also Read: Top Health Tips from the Celebrities in Best Shape
How do they work?
The pills work by attacking the virus’s genetic material, according to a new study published in the journal Nature.
Scientists have known since the early days of the pandemic that certain drugs, called nucleoside analogs, can inhibit the replication of SARS-CoV-2, the coronavirus that causes COVID-19. These drugs are already approved for other viruses, such as hepatitis C. But it wasn’t clear how well they would work against SARS-CoV-2.
In the new study, a team of international researchers led by scientists at Emory University and the drug company Gilead Sciences used a technique called cryo-electron microscopy to visualize how one nucleoside analog, remdesivir (also known as Veklury), interacts with SARS-CoV-2’s viral RNA.
They found that remdesivir docks onto a part of the viral RNA called the cap, which is essential for viral replication. Once remdesivir is bound to the cap, it prevents other molecules from binding there and starting replication. The findings suggest that nucleoside analogs could be effective against other RNA viruses as well.
What do scientists still want to know about them?
The effects of COVID-19 on the body are still largely unknown. Scientists are still working to understand how the virus works and what treatments are most effective against it.
One area of research that is still ongoing is the study of antiviral drugs that could be used to treat COVID-19. While there are some promising drugs being developed, there is still much that scientists don’t know about them.
For example, it’s not yet clear if these drugs are safe for use in humans. Some of them have only been tested on animals so far. Additionally, scientists don’t yet know what the ideal dosage of these drugs would be for humans.
Coverage: Covid Pregnancies Symptoms Risks and Delivery
Another question that scientists are still trying to answer is how long these drugs will remain effective against the virus. Will they need to be taken for a prolonged period of time, or will a single course of treatment be enough?
Finally, scientists are also working to understand more about the side effects of these antiviral drugs. In some cases, they can cause serious side effects like liver damage or gastrointestinal problems. Researchers need to better understand these risks before these drugs can be widely used in humans.
While there is still much to learn about antiviral drugs for COVID-19, researchers are making progress in understanding them better. With more research, it’s hoped that these drugs will eventually become a safe and effective treatment option for people with this virus.
Are they safe?
As the world anxiously awaits a COVID-19 vaccine, scientists are also working on antiviral pills that could be used to treat the virus. But are these pills safe?
There is still much unknown about the safety of these pills, as they have not yet been fully tested. However, scientists are hopeful that they will be safe and effective in treating COVID-19.
It is important to note that these antiviral pills are not a cure for COVID-19, but they could potentially help to lessen the severity of symptoms and shorten the duration of the illness. More research is needed to determine the full safety and efficacy of these treatments.
How effective are they?
The effectiveness of antiviral drugs for COVID-19 is still being studied. While some preliminary studies have shown promise, more research is needed to determine whether these drugs are safe and effective for treating the virus.
One study published in the journal Nature Medicine found that the antiviral drug remdesivir may be effective in treating COVID-19. The study found that patients who received the drug had a shorter hospital stay and required less oxygen than those who did not receive the drug. However, the study was small and more research is needed to confirm these findings.
Another study published in the New England Journal of Medicine evaluated the effectiveness of the antiviral drug lopinavir-ritonavir in treating COVID-19. The study found that patients receiving the drug had a slightly lower risk of death than those who did not receive the drug. However, the difference was not statistically significant, meaning it could have been due to chance. More research is needed to determine whether lopinavir-ritonavir is an effective treatment for COVID-19.
Will the drugs work against variants of concern?
As new variants of SARS-CoV-2, the virus that causes COVID-19, circulate around the world, scientists are working to understand if and how existing drugs could work against these new strains.
There are currently four antiviral drugs approved by the FDA for emergency use against COVID-19: remdesivir, hydroxychloroquine, chloroquine, and favipiravir. So far, there is no evidence that any of these drugs are effective against the new variants of concern.
Scientists are still studying how well these drugs work against SARS-CoV-2 and whether or not they are effective against the new variants. It is possible that some of these drugs may be effective against certain variants and not others. More research is needed to determine which drugs may be effective against which variants.
Could the coronavirus become resistant to antivirals?
The coronavirus pandemic has led to a race to develop antiviral drugs that can treat the disease. But could the virus become resistant to these drugs?
There is still much unknown about the coronavirus and how it behaves. However, scientists are monitoring the situation closely and say that it is unlikely that the virus will develop resistance to antiviral drugs.
The main reason for this is that viruses typically mutate very quickly, which would make it difficult for them to develop resistance to a drug that is constantly changing. Additionally, there are already several different types of antiviral drugs being developed, so even if one type were to become less effective, there would be others to take its place.
Still, it’s important to continue researching this possibility and developing new antiviral drugs, just in case. The more we know about the virus and how it behaves, the better prepared we’ll be to fight it.
Who will be able to access the new drugs?
The new drugs will be available to everyone, but scientists still have a lot to learn about them. The drugs are being developed by different companies and they have not been tested on humans yet. So far, they have only been tested on animals.
Conclusion
The race to develop a COVID-19 antiviral treatment is still ongoing, and scientists are working tirelessly to find a safe and effective way to treat the virus. While there are many potential treatments in development, it’s still too early to say which one will be the most effective. However, the use of COVID antiviral pills is promising and scientists are hopeful that they will be able to find a treatment that can help people recover from the virus quickly and safely.
